Objective:

To examine recent advances and emerging trends in intraocular tamponade agents for retinal detachment repair, focusing on clinical applications, efficacy, and safety considerations.

Approach:

• Tamponade Selection: Contemporary selection has evolved from a simple choice between gas and silicone oil to a tailored decision based on break location, PVR risk, likelihood of a second surgery, and patient compliance.
• Gas Tamponades: Expansile gases like SF6 and C3F8 are first-line for uncomplicated RDs, particularly with superior breaks. Hexafluoroethane offers an intermediate duration.
• Silicone Oil Use: Silicone oil is essential for complex detachments and has a unique complication profile, including cataract formation and ocular hypertension.
• Heavy Silicone Oils: Heavy silicone oils provide improved mechanical support for inferior breaks and have shown better outcomes in complex inferior RDs.
• Perfluorocarbon Liquids: PFCLs serve as intraoperative tools for retinal stabilization but are limited to brief durations due to risks of retinal toxicity.

Key Findings:

• Current tamponade agents are imperfect compromises between efficacy and safety.
• Silicone oil is superior to SF6 in managing complex PVR but not C3F8.
• Heavy silicone oils have improved evidence for use in inferior detachments.
• PFCLs are effective for short-term stabilization but carry risks of toxicity.
• Silicone oil introduces complications such as emulsification and potential visual loss.
• Heavy silicone oils are not approved for clinical use in the U.S.
• PFCLs are restricted to brief exposure times due to toxicity risks.

Interpretation:

Recent innovations focus on refining established tamponades and improving patient selection and postoperative protocols.

Limitations:

• Silicone oil introduces complications such as emulsification and potential visual loss.
• Heavy silicone oils are not approved for clinical use in the U.S.
• PFCLs are restricted to brief exposure times due to toxicity risks.

Conclusion:

Advancements in intraocular tamponade agents emphasize tailored approaches and complication management in retinal detachment repair.